Valeant And Watson Buy Into Generics | May 30, 2011 Issue - Vol. 89 Issue 22 | Chemical & Engineering News
Volume 89 Issue 22 | p. 27 | Concentrates
Issue Date: May 30, 2011

Valeant And Watson Buy Into Generics

Department: Business
Keywords: pharmaceuticals, acquisitions, generic drugs

Looking to spend its money after failing to take over Cephalon, Valeant Pharmaceuticals will acquire the specialty drug firm AB Sanitas for about $443 million in cash. Based in Kaunas, Lithuania, Sanitas sells branded generic drugs throughout Central and Eastern Europe. Valeant expects its sales to reach more than $140 million this year. Separately, Watson Pharmaceuticals has bought the generic drug maker Specifar Pharmaceuticals for $562 million. The Greek firm had 2010 sales of about $120 million.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment